THE EPIDEMIOLOGY OF CARCINOID-TUMORS IN ENGLAND AND SCOTLAND

被引:71
作者
NEWTON, JN
SWERDLOW, AJ
SILVA, IMD
VESSEY, MP
GRAHAMESMITH, DG
PRIMATESTA, P
REYNOLDS, DJM
机构
[1] LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,EPIDEMIOL MONITORING UNIT,LONDON WC1 7HT,ENGLAND
[2] UNIV OXFORD,RADCLIFFE INFIRM,DEPT PUBL HLTH & PRIMARY CARE,OXFORD OX2 6HE,ENGLAND
[3] UNIV OXFORD,RADCLIFFE INFIRM,DEPT CLIN PHARMACOL,CLIN PHARMACOL UNIT,OXFORD OX2 6HE,ENGLAND
基金
英国医学研究理事会;
关键词
D O I
10.1038/bjc.1994.424
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Relatively little is known about the epidemiology of carcinoid tumours in contrast to the extensive information available on their biochemical effects and natural history. Accordingly, we have used cancer registrations in England from 1979 to 1987, and in Scotland from 1980 to 1989, to estimate the incidence of carcinoid tumours in Britain. Age-standardised incidence rates for England, based on 3,382 registrations, were 0.71 (0.68-0.75) for men and 0.87 (0.83-0.91) for women, per 100,000 per year. The equivalent rates for Scotland, based on 639 registrations, were 1.17 (0.91-1.44) for men and 1.36 (1.09-1.63) for women. There was a consistent female excess of carcinoid tumours in the reproductive years, which was reversed after the age of 50. The female excess was most striking for gastrointestinal carcinoid tumours in women aged 15-19 years (F:M ratio = 2.14). The sex differences are probably due in part to incidental diagnosis of carcinoid tumours during abdominal procedures, which are more common in women than men at ages 15-49 years. However, there is some evidence to suggest a true sex difference in incidence, particularly the fact that the sex ratio for thoracic tumours varies with age in a similar way to that for gastrointestinal tumours. Hormonal factors may, therefore, be important in the aetiology of carcinoid tumours.
引用
收藏
页码:939 / 942
页数:4
相关论文
共 24 条
  • [1] BASSER R L, 1991, Current Opinion in Oncology, V3, P109, DOI 10.1097/00001622-199102000-00016
  • [2] BERGE T, 1976, ACTA PATH MICRO IM A, V84, P322
  • [3] Cassidy M, 1934, Proc R Soc Med, V27, P220
  • [4] GODWIN JD, 1975, CANCER, V36, P560, DOI 10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO
  • [5] 2-4
  • [6] GRAHAMESMITH DG, 1972, CARCINOID SYNDROME
  • [7] KESHGEGIAN AA, 1980, CANCER, V45, P293, DOI 10.1002/1097-0142(19800115)45:2<293::AID-CNCR2820450216>3.0.CO
  • [8] 2-5
  • [10] TAMOXIFEN THERAPY FOR METASTATIC CARCINOID-TUMOR - A NEGATIVE STUDY
    MOERTEL, CG
    ENGSTROM, PF
    SCHUTT, AJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (04) : 531 - 532